[1]
“Comparison of the renal response of bortezomib-based induction and conventional regimen in multiple myeloma patients with renal failure”, Ann Med Res , vol. 28, no. 10, pp. 1824–1829, Oct. 2021, Accessed: Mar. 14, 2025. [Online]. Available: https://annalsmedres.org/index.php/aomr/article/view/3934